Validation of a disease-specific quality-of-life questionnaire in a large sample of Dutch achalasia patients

Diseases of the Esophagus

Volumn 21, Issue 6, 2008, Pages 544-550

  Frankhuisen, R ^a   Heijkoop, R ^a   van Herwaarden, M A ^a   de Vries, D R ^a   Smout, A J P M ^a   Baron, A ^a   Samsom, M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Achalasia; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; ESOPHAGUS ACHALASIA; FACTORIAL ANALYSIS; FEASIBILITY STUDY; FEMALE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REMISSION; SYMPTOMATOLOGY; VALIDATION STUDY;

EID: 51249114487     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2008.00815.x     Document Type: Article

References (17)

1. Csendes A, Braghetto I, Henriquez A, Cortes C. Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut 1989; 30: 299-304.
2. Eckardt V F, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004; 53: 629-33.
3. Testa M A, Simonson D C. Assessment of quality-of-life outcomes. N Engl J Med 1996; 334: 835-40.
4. Guyatt G H, Feeny D H, Patrick D L. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-9.
5. Urbach D R, Tomlinson G A, Harnish J L, Martino R, Diamant N E. A measure of disease-specific health-related quality of life for achalasia. Am J Gastroenterol 2005; 100: 1668-76.
6. Spechler S J, Castell D O. Classification of oesophageal motility abnormalities. Gut 2001; 49: 145-51.
7. Eckardt V F, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992; 103: 1732-8.
8. Eckardt V F, Stauf B, Bernhard G. Chest pain in achalasia: Patient characteristics and clinical course. Gastroenterology 1999; 116: 1300-4.
9. Hunt S M, Mckenna S P. Validating the Sf-36. Br Med J 1992 305: 645.
10. Mant J W F, Jenkinson C, Murphy M F G, Clipsham K, Marshall P, Vessey M P. Use of the Short Form-36 to detect the influence of upper gastrointestinal disease on self-reported health status. Qual Life Res 1998; 7: 221-6.
11. Ware J E, Sherbourne C D. The Mos 36-Item Short-Form Health Survey (Sf-36). 1. Conceptual-framework and item selection. Med Care 1992; 30: 473-83.
12. Aaronson N K, Muller M, Cohen P D et al. Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 1055-68.
13. Ware J. SF 36 health survey, manuel and interpretation guide. Boston: Medical Outcomes Trust, 1994.
14. Reckase M. Unifactor latent trait models applied to multifactor tests: results and implications. J Educ Stat 1979; 4: 207-30.
15. Kerlinger F N. Foundations of Behavioral Research. New York: Holt, Rinehart and Winston, 1973.
16. Talley N J, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: An overview of available measures. Qual Life Res 2005; 14: 21-33.
17. Talley N J, Haque M, Wyeth J W et al. Development of a new dyspepsia impact scale: The Nepean Dyspepsia Index. Aliment Pharmacol Ther 1999; 13: 225-35.